Skip to main content
Message Font: Serif | Sans-Serif
No. of Recommendations: 3

Alot of this we've heard before, but CareDx really seems like a lower risk healthcare play that looks like a market beater. It may not necessarily 10x, but I think it has a better risk probably file than GH. GH does have a lot larger TAM, but they need to piecemeal the individual "residual disease" tests, so they're fragmenting the market a bit.

CareDx owns their market. GH plays in a hypercompetitive space. With that said, if you wanted to own both, I wouldn't blame ya!
Print the post Back To Top